Letter: Safety after cessation of nucleos(t)ide analogue therapy in patients with chronic hepatitis B infection

Aliment Pharmacol Ther. 2023 Oct;58(7):731-732. doi: 10.1111/apt.17657.

Authors

Yen-Chun Liu^{1

2}, Wen-Juei Jeng^{1

2}, Rong-Nan Chien^{1

2

3}

Affiliations

¹ College of Medicine, Chang Gung University, Taipei, Taiwan.
² Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
³ Liver Research Unit, Chang Gung Memorial Hospital, Taoyuan, Taiwan.

PMID: 37702033
DOI: 10.1111/apt.17657

No abstract available

Publication types

Letter
Comment

MeSH terms

Hepatitis B*
Hepatitis B, Chronic* / drug therapy
Humans